𝛼SK or Search

ENTITY

CureVac NV (CVAC US)

14

Analysis

Health Care • United States

CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.

more

Refresh

Exchange Announcement • 04 Dec 2025 05:32

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 27 Nov 2025 05:34

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 12 Nov 2025 21:01

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 12 Nov 2025 21:00

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 23 Oct 2025 04:05

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x